Testing effectiveness (Phase 2)Ended earlyNCT01339455What this trial is testingAutologous Hematopoietic Stem Cell Transplant in Neuromyelitis OpticaWho this might be right forNeuromyelitis Optica University of Calgary 3
Not applicableStudy completedNCT04629274What this trial is testingIn Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMOWho this might be right forNeuromyelitis Optica Imcyse SA 15
Not applicableStudy completedNCT03942952What this trial is testingPEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.Who this might be right forMultiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more University of Texas Southwestern Medical Center 49
Large-scale testing (Phase 3)Study completedNCT02073279What this trial is testingEfficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)Who this might be right forNeuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD) Hoffmann-La Roche 95
Very early researchWithdrawnNCT06548620What this trial is testingRD06-04 in Patients With Active Autoimmune DiseasesWho this might be right forSLESclerosisANCA Associated Vasculitis+5 more Nanjing Bioheng Biotech Co., Ltd.
Not applicableLooking for participantsNCT05566769What this trial is testingPerformance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSDWho this might be right forNeuromyelitis Optica Ad scientiam 103
Not applicableNot Yet RecruitingNCT07182409What this trial is testingEfficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum DisorderWho this might be right forNMOSD First Affiliated Hospital of Chongqing Medical University 40
Large-scale testing (Phase 3)WithdrawnNCT03829566What this trial is testingAutologous Transplant To End NMO Spectrum DisorderWho this might be right forNeuromyelitis OpticaDevic's DiseaseNMO Spectrum Disorder Northwestern University
Not applicableLooking for participantsNCT06280755What this trial is testingClinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.Who this might be right forMultiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more icometrix 7,000
Not applicableLooking for participantsNCT06443333What this trial is testingNational, Multicentric Registry Study on Neuroimmunological Diseases in ChinaWho this might be right forMultiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more Xuanwu Hospital, Beijing 7,000
Testing effectiveness (Phase 2)WithdrawnNCT05974293What this trial is testingA Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum DisordersWho this might be right forNMO Spectrum DisorderSpasticity, Muscle Michael, Levy M.D.,Ph.D.
Early research (Phase 1)Study completedNCT01759602What this trial is testingC1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica ExacerbationWho this might be right forNeuromyelitis Optica Michael Levy 10
Large-scale testing (Phase 3)Study completedNCT02028884What this trial is testingEfficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)Who this might be right forNeuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD) Hoffmann-La Roche 85
Testing effectiveness (Phase 2)Study completedNCT02865018What this trial is testingNeuromyelitis Optica (NMO) & CetirizineWho this might be right forNeuromyelitis Optica Icahn School of Medicine at Mount Sinai 16
Testing effectiveness (Phase 2)Looking for participantsNCT07184840What this trial is testingEculizumab For the Acute Attack of Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis Optica Spectrum Disorder Attack Tianjin Medical University General Hospital 110
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138What this trial is testingSafety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum DisordersWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder Tianjin Medical University General Hospital 135
Not applicableUnknownNCT05414890What this trial is testingSensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen DeterminationWho this might be right forNMO Spectrum DisorderNMDA-R EncephalitisDiagnostic Self Evaluation+4 more Beijing Tiantan Hospital 2,500
Early research (Phase 1)Study completedNCT05432713What this trial is testingLP-168 in Healthy VolunteersWho this might be right forMultiple SclerosisNMO Spectrum Disorder Guangzhou Lupeng Pharmaceutical Company LTD. 70
Large-scale testing (Phase 3)Ended earlyNCT04155424What this trial is testingThe Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum DisorderWho this might be right forNeuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 5
Not applicableNot Yet RecruitingNCT07304960What this trial is testingMultiple Sclerosis Versus Neuromyelitis Optica Spectrum DisorderWho this might be right forMS (Multiple Sclerosis)NMO Spectrum Disorder (NMOSD) Assiut University 100